Description
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Purity | ≥98% |
|---|---|
| Formula | C108H167N27O29 |
| Formula Wt. | 2307.67 |
| Synonym | HIV Endonuclease Antigenic Site; HIV Endonuclease. |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Rahman MA, Kuse N, Murakoshi H, et al. Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition. Microbes Infect. 2014 May;16(5):434-8. PMID: 24657622.
Cdc42 GTPase inhibitor.
Antihistamine with potential neuroprotective ac...
Mycotoxin produced by Aspergillus; actin polyme...
γ-Secretase inhibitor.
α1-adrenergic antagonist.
Tropane alkaloid found in Solanaceae plants; M1...
Flavanone glycoside found in citrus fruit; SERM...
Mineralocorticoid antagonist.
Macrocyclic lactone avermectin; GABA antagonist...
5-HT2A antagonist, potential α1-adrenergic ant...
FabI inhibitor
Imidazotetrazine, DNA alkylator.
5-FU prodrug; thymidylate synthase inhibitor.
Inhibitor of ALK2, ALK3, ALK6, and AMPK.
AKT inhibitor, potential ROCK, p70S6K, PKA, MKK...
Impurity of diclofenac
Peptide fragment, renin substrate, precursor to...
Dipeptide; aminopeptidase (N/CD13) inhibitor.
ERK1/2 inhibitor.
Negative control for PKC activation.